E-mail not displaying correctly? View it in your browser.
Our Products
& Services

Click to find
more about our


In this newsletter

High content screening application note from InSphero and PerkinElmer is featured in Nature Methods
Nature Methods recently featured a high content screening application note, co-authored by InSphero and PerkinElmer, showing how different characteristics of 3D microtissues can be analysed using the Operetta® High Content Imaging System. Find more here.

Last chance to register: User Group Meetings on 3D cell culture in BOS on Oct 29 and SFO on Nov 1
Register today to meet experts in the use of 3D cell culture in efficacy and toxicology testing at our half- to full-day meetings in Boston and San Francisco. The speaker panel includes Richard M. Neve (Genentech), Caitlin Brown and Timothy Moeller (Celsis In Vitro Technologies). View the program or register by e-mail now!

*** Free participation for all InSphero customers! ***

3D cell culture literature picks – Oct 2012
Our applications team has reviewed a small selection of current 3D-cell-culture journal papers  to keep you updated about recent developments in 3D.
New job opening: Laboratory Technician, 80-100%
Join our team as Laboratory Technician at InSphero's R&D and production site in Zurich. If you would relish a new challenge in an entrepreneurial and fast-growing company, we would like to hear from you! View the full job advertisement.

Meet InSphero at fairs & events
Meet the InSphero team at upcoming fairs, conferences and meetings to learn how 3D microtissues accelerate the process of drug discovery and development. Arrange a meeting, a webinar or register for User Group Meeting.
About InSphero

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company, headquartered in Zurich, Switzerland, currently counts 7 of the top ten global pharmaceutical and cosmetics companies as customers, and is helping them implement the company’s patent-pending microtissue technology in their development work-flow. InSphero 3D Insight™ Microtissues enable more biologically relevant in vitro applications in efficacy (e.g. in oncology) and toxicology, including long-term and inflammation-mediated toxicity. A broad portfolio of tumor and liver microtissues is available from a number of cell sources, with additional toxicology models in the pipeline. The spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich has been recognised for its scientific and commercial achievements with a number of national and international awards and is also certified to the ISO 9001:2008 standard for its Quality Management System.

Our mailing address is:
InSphero Inc.
74 Orion St
Brunswick, ME 04011-5031

Copyright (C) 2012 InSphero Inc. All rights reserved.